Latest

neuropharmacology

·March 28, 2020·3 min read

FDA approves ozanimod for treatment of multiple sclerosis

The FDA has approved a new drug named Ozanimod for the treatment of multiple sclerosis. Ozanimod binds to receptors in lymphocytes' surfaces, preventing them from reaching the brain. As the number of active lymphocytes decreases, the attack on the immune system diminishes.

This shows a man looking out of a window

Featured Neuroscience Open Neuroscience Articles Psychology

·February 20, 2020·3 min read

Extended antidepressant use creates physical dependence

Long-term use of antidepressants can create physical dependence and severe withdrawal symptoms for patients looking to stop their treatment. Patients who quit their medication often experience Antidepressant Discontinuation Syndrome, which results in flu-like symptoms, insomnia, nausea, and other symptoms associated with withdrawal.

Featured Neurology Neuroscience Open Neuroscience Articles

·February 16, 2020·4 min read

Cough syrup drug being trialed as Parkinson’s treatment

Ambroxol, a medication approved to treat coughs, may slow the progression of Parkinson's disease. The medication is able to effectively cross the blood-brain barrier and increases levels of GCase in patients' brains. Ambroxol also appears to reduce Parkinson's-related alpha-synuclein levels.

This shows a brain and a swirly background

Brain Cancer Featured Neuroscience Psychology

·February 2, 2020·5 min read

Single dose of psilocybin reduces depression and anxiety for a year in cancer patients

A single dose of the psychedelic psilocybin reduces depression, anxiety, and feelings of hopelessness in cancer patients for 12 months after the drug is administered.

This shows a psychedelic face and flowers

Featured Neuroscience Psychology

·January 28, 2020·5 min read

Could psychedelics help treat mental health and resolve the climate crisis?

Numerous recent studies claim psychedelics, such as psilocybin, can help treat a range of mental health problems from depression to PTSD. Researchers investigate how psychedelics can help us become more "nature-connected" and increase a sense of environmental responsibility.

Autism Featured Neuroscience Open Neuroscience Articles

·January 27, 2020·7 min read

Prescription drug improves symptoms of autism by targeting brain’s chemical messengers

A drug commonly prescribed for edema improves the symptoms for young children on the autism spectrum with no significant side effects. The drug, bumetanide, decreases the ratio of GABA to glutamate in the brain.

This shows an old man sitting on a park bench

Featured Neurology Neuroscience

·January 25, 2020·5 min read

Lithium may halt Alzheimer’s progression

More commonly associated with treating bipolar disorder, microdoses of lithium may halt the progression of Alzheimer's disease.

This shows an older woman with a walking stick

Featured Neurology Neuroscience

·January 20, 2020·5 min read

Racial disparities in drug prescriptions for dementia

Study reveals racial disparities in access to the correct medications for Alzheimer's patients. Asian and black patients are less likely to be prescribed anti-dementia medications and have an increased likelihood of being prescribed antipsychotic medications.

Brain Cancer Featured Neurology Neuroscience

·January 16, 2020·3 min read

Improved brain chip for precision treatment of brain cancer

A new brain chip allows multiple simultaneous drugs to be administered directly to glioblastoma brain cancer tumors.

Featured Genetics Neurology Neuroscience Open Neuroscience Articles

·January 10, 2020·2 min read

Antibiotics could be promising treatment for form of dementia

Gentamicin and G418, two aminoglycoside antibiotics, were effective at correcting genetic mutations associated with a specific form of frontotemporal dementia. The findings are promising for the treatment of frontotemporal dementia.